Figure 3. Comparison of overall survival, disease-free survival, locoregional recurrence-free survival and distant metastasis-free survival between the patients with favorable and unfavorable pathologic responses (upper panel), between favorable pathologic responses and the control group (middle panel), and between unfavorable pathologic responses and the control group (lower panel).
